Canine cognitive dysfunction (dog dementia): signs, diagnosis and support

Canine cognitive dysfunction syndrome (CDS) — often described as dog dementia — is a neurodegenerative condition of older dogs characterised by a decline in memory, learning, perception and awareness. Its pathology shares features with Alzheimer's disease in humans: accumulation of amyloid-beta plaques, neurofibrillary tangles and progressive neuronal loss. It is not a normal part of ageing, but it is common: studies estimate it affects around 14% of dogs aged 8 years, rising to 28–68% of dogs over 15 years (prevalence varies by study methodology and age cohort — lower estimates typically come from owner-reported surveys of specific behaviours; higher estimates from structured clinical assessments across broader senior populations).

Despite its prevalence, CDS is frequently under-recognised. Owners and sometimes even clinicians attribute its signs to "normal slowing down," missing the opportunity for earlier intervention. While there is no cure, early diagnosis allows for management strategies that can slow progression and maintain quality of life.

The DISHA framework: recognising the signs

The DISHA acronym (developed by veterinary behaviourists) groups the main clinical signs into five categories and is a widely used screening tool in clinical practice.

• D — Disorientation: appearing lost in familiar environments; staring blankly at walls or into space; getting "stuck" in corners or behind furniture; seeming confused about the purpose of familiar objects
• I — (Changes in) Interactions: reduced engagement with people and other pets; less interest in greeting or being petted; in some dogs, increased clinginess or separation anxiety
• S — Sleep-wake cycle disruption: sleeping more during the day, restlessness or vocalisation at night (nocturnal pacing and howling are characteristic); effectively a reversal of normal sleep patterns
• H — House-soiling: urinating or defecating indoors in a previously reliable dog; going to the wrong location or failing to signal the need to go outside
• A — Activity changes: reduced interest in play, exploration or interaction; repetitive, purposeless behaviours (circling, licking, pacing); reduced response to previously exciting stimuli

Diagnosis

There is no single definitive test for CDS in living dogs (definitive diagnosis requires post-mortem neuropathology). Clinical diagnosis is based on: a thorough behavioural history using a validated tool such as the Canine Cognitive Dysfunction Rating scale (CCDR) or the Canine Dementia Scale (CADES); physical and neurological examination; exclusion of other causes via bloodwork, urinalysis, blood pressure and, where indicated, MRI or CT imaging of the brain.

Management: what the evidence supports

A multimodal approach combines environmental management, cognitive enrichment, dietary support and, where appropriate, medication.

• Selegiline (L-deprenyl, brand: Anipryl): the only licensed veterinary pharmaceutical for CDS in dogs in some countries; a monoamine oxidase B inhibitor that increases dopamine and other neurotransmitter activity; evidence shows improvement in DISHA signs in a proportion of treated dogs
• Medium-chain triglycerides (MCT oil): provide an alternative brain energy substrate bypassing impaired glucose metabolism; clinical evidence in dogs supports cognitive benefit at appropriate doses
• Antioxidants (vitamin E, vitamin C, selenium, beta-carotene): oxidative stress is a key mechanism in CDS; some senior and cognitive-support diets are formulated with antioxidant blends
• Omega-3 fatty acids (EPA/DHA): anti-inflammatory and neuroprotective; a reasonable adjunct given the general evidence base
• S-adenosyl methionine (SAMe): involved in neurotransmitter synthesis; some studies suggest cognitive benefit; available as a supplement
• Environmental enrichment: puzzle feeders, gentle training, scent games, novel objects — "use it or lose it" applies to the dog brain; mentally stimulating activities slow decline
• Structured routine: predictable feeding, walking and bedtime schedules reduce confusion and anxiety
• Night-time management: night lights, a sleeping area close to the owner, and in some cases short-term anxiolytics prescribed by a vet to manage nocturnal vocalisation

Supporting the dog and the owner

CDS can be emotionally draining for owners. Caring for a dog who may not recognise familiar surroundings, soils the house or vocalises through the night takes a toll. Recognising that this is a disease process — not stubbornness, not a failing of training — is important. Connecting with a veterinary behaviourist or a senior-care-focused vet can provide both clinical support and practical strategies for managing the day-to-day challenges.